CAS 77263-06-0: (6aR,11aR)-6a,11a-Dihydro-2,10-bis(3-methyl-2-buten-1-yl)-6H-benzofuro[3,2-c][1]benzopyran-3,9-diol

Erythrabyssin II is a biflavonoid compound, which is a type of secondary metabolite primarily sourced from specific plant species within the genus *Erythrina*. This compound is known for its unique and complex chemical structure, which contributes to its notable biological activities. It functions through a multifaceted mode of action that involves modulation of immune responses, inhibition of certain enzyme activities, and potential antioxidant properties. These features make Erythrabyssin II of significant interest in pharmacological research and applications. The main uses and applications of Erythrabyssin II include its exploration as a potential therapeutic agent in immunology and cancer research. By modulating immune cell activity and influencing inflammatory pathways, it holds promise in the development of treatments for autoimmune diseases and cancer. Additionally, its antioxidant properties suggest a role in combating oxidative stress-related conditions. As a compound derived from natural plant sources, Erythrabyssin II also draws interest in studies aimed at discovering novel, naturally-derived therapeutic agents. Further research is ongoing to fully elucidate its mechanism of action and therapeutic potential.

Erythrabyssin II combats Staph/Strep (MIC 0.78-1.56 μg/ml) and inhibits bacterial neuraminidase (IC50 0.09-3.25 μM).